XML 115 R104.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Revenue by Product) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue from External Customer [Line Items]        
Total revenues $ 3,871.7 $ 3,697.6 $ 11,556.9 $ 11,015.7
Product sales        
Revenue from External Customer [Line Items]        
Total revenues 3,752.8 3,533.8 11,198.5 10,537.9
Immunology        
Revenue from External Customer [Line Items]        
Total revenues 1,197.2 1,070.1 3,472.6 3,129.0
IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 655.9 605.1 1,825.9 1,613.9
HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Total revenues 329.0 268.4 1,063.0 968.4
BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Total revenues 212.3 196.6 583.7 546.7
Hematology        
Revenue from External Customer [Line Items]        
Total revenues 905.0 916.0 2,808.6 2,751.5
HEMOPHILIA        
Revenue from External Customer [Line Items]        
Total revenues 735.9 725.3 2,225.4 2,119.6
INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 169.1 190.7 583.2 631.9
Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 731.7 691.1 2,170.1 1,979.8
VYVANSE        
Revenue from External Customer [Line Items]        
Total revenues 595.0 538.4 1,779.8 1,620.3
ADDERALL XR        
Revenue from External Customer [Line Items]        
Total revenues 76.3 106.0 232.1 242.3
MYDAYIS        
Revenue from External Customer [Line Items]        
Total revenues 19.3 10.2 40.4 25.9
Other Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 41.1 36.5 117.8 91.3
Genetic Diseases        
Revenue from External Customer [Line Items]        
Total revenues 381.4 359.7 1,105.6 1,060.8
ELAPRASE        
Revenue from External Customer [Line Items]        
Total revenues 170.6 152.9 465.5 454.5
REPLAGAL        
Revenue from External Customer [Line Items]        
Total revenues 123.0 117.2 372.8 349.0
VPRIV        
Revenue from External Customer [Line Items]        
Total revenues 87.8 89.6 267.3 257.3
Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 216.5 190.5 608.5 816.4
LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Total revenues 119.1 86.7 287.0 469.6
PENTASA        
Revenue from External Customer [Line Items]        
Total revenues 65.7 72.1 215.6 224.5
Other Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 31.7 31.7 105.9 122.3
Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 177.1 160.5 588.9 437.7
GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Total revenues 97.1 84.9 326.8 229.2
NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Total revenues 51.0 39.1 160.8 103.3
Other Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 29.0 36.5 101.3 105.2
Ophthalmics        
Revenue from External Customer [Line Items]        
Total revenues 93.4 77.4 255.8 173.4
Oncology        
Revenue from External Customer [Line Items]        
Total revenues 50.5 68.5 188.4 189.3
Royalties        
Revenue from External Customer [Line Items]        
Total revenues 45.1 111.4 175.4 329.7
Other revenues        
Revenue from External Customer [Line Items]        
Total revenues 73.8 52.4 183.0 148.1
Royalties and other revenues        
Revenue from External Customer [Line Items]        
Total revenues 118.9 163.8 358.4 477.8
United States | Product sales        
Revenue from External Customer [Line Items]        
Total revenues 2,467.0 2,290.6 7,272.4 6,950.6
United States | Immunology        
Revenue from External Customer [Line Items]        
Total revenues 913.9 808.7 2,614.3 2,410.7
United States | IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 530.7 486.6 1,409.6 1,299.9
United States | HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Total revenues 291.3 235.8 254.8 878.9
United States | BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Total revenues 91.9 86.3 949.9 231.9
United States | Hematology        
Revenue from External Customer [Line Items]        
Total revenues 431.3 428.1 1,313.1 1,299.5
United States | HEMOPHILIA        
Revenue from External Customer [Line Items]        
Total revenues 386.6 357.5 1,152.6 1,082.1
United States | INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 44.7 70.6 160.5 217.4
United States | Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 620.2 593.1 1,838.1 1,710.7
United States | VYVANSE        
Revenue from External Customer [Line Items]        
Total revenues 528.5 476.8 1,572.3 1,445.4
United States | ADDERALL XR        
Revenue from External Customer [Line Items]        
Total revenues 71.5 99.4 219.4 225.9
United States | MYDAYIS        
Revenue from External Customer [Line Items]        
Total revenues 19.3 10.2 40.4 25.9
United States | Other Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 0.9 6.7 6.0 13.5
United States | Genetic Diseases        
Revenue from External Customer [Line Items]        
Total revenues 80.7 78.9 240.5 229.7
United States | ELAPRASE        
Revenue from External Customer [Line Items]        
Total revenues 41.7 41.4 126.6 119.4
United States | REPLAGAL        
Revenue from External Customer [Line Items]        
Total revenues 0.0 0.0 0.0 0.0
United States | VPRIV        
Revenue from External Customer [Line Items]        
Total revenues 39.0 37.5 113.9 110.3
United States | Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 165.3 144.9 454.2 693.5
United States | LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Total revenues 88.9 61.4 194.8 402.0
United States | PENTASA        
Revenue from External Customer [Line Items]        
Total revenues 65.7 72.1 215.6 224.5
United States | Other Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 10.7 11.4 43.8 67.0
United States | Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 130.1 112.3 434.5 297.8
United States | GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Total revenues 82.2 72.6 280.2 193.3
United States | NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Total revenues 47.8 39.1 153.5 103.2
United States | Other Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 0.1 0.6 0.8 1.3
United States | Ophthalmics        
Revenue from External Customer [Line Items]        
Total revenues 92.1 77.4 252.9 173.4
United States | Oncology        
Revenue from External Customer [Line Items]        
Total revenues 33.4 47.2 124.8 135.3
International | Product sales        
Revenue from External Customer [Line Items]        
Total revenues 1,285.8 1,243.2 3,926.1 3,587.3
International | Immunology        
Revenue from External Customer [Line Items]        
Total revenues 283.3 261.4 858.3 718.3
International | IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 125.2 118.5 416.3 314.0
International | HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Total revenues 37.7 32.6 328.9 89.5
International | BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Total revenues 120.4 110.3 113.1 314.8
International | Hematology        
Revenue from External Customer [Line Items]        
Total revenues 473.7 487.9 1,495.5 1,452.0
International | HEMOPHILIA        
Revenue from External Customer [Line Items]        
Total revenues 349.3 367.8 1,072.8 1,037.5
International | INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Total revenues 124.4 120.1 422.7 414.5
International | Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 111.5 98.0 332.0 269.1
International | VYVANSE        
Revenue from External Customer [Line Items]        
Total revenues 66.5 61.6 207.5 174.9
International | ADDERALL XR        
Revenue from External Customer [Line Items]        
Total revenues 4.8 6.6 12.7 16.4
International | MYDAYIS        
Revenue from External Customer [Line Items]        
Total revenues 0.0 0.0 0.0 0.0
International | Other Neuroscience        
Revenue from External Customer [Line Items]        
Total revenues 40.2 29.8 111.8 77.8
International | Genetic Diseases        
Revenue from External Customer [Line Items]        
Total revenues 300.7 280.8 865.1 831.1
International | ELAPRASE        
Revenue from External Customer [Line Items]        
Total revenues 128.9 111.5 338.9 335.1
International | REPLAGAL        
Revenue from External Customer [Line Items]        
Total revenues 123.0 117.2 372.8 349.0
International | VPRIV        
Revenue from External Customer [Line Items]        
Total revenues 48.8 52.1 153.4 147.0
International | Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 51.2 45.6 154.3 122.9
International | LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Total revenues 30.2 25.3 92.2 67.6
International | PENTASA        
Revenue from External Customer [Line Items]        
Total revenues 0.0 0.0 0.0 0.0
International | Other Established Brands        
Revenue from External Customer [Line Items]        
Total revenues 21.0 20.3 62.1 55.3
International | Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 47.0 48.2 154.4 139.9
International | GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Total revenues 14.9 12.3 46.6 35.9
International | NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Total revenues 3.2 0.0 7.3 0.1
International | Other Internal Medicine        
Revenue from External Customer [Line Items]        
Total revenues 28.9 35.9 100.5 103.9
International | Ophthalmics        
Revenue from External Customer [Line Items]        
Total revenues 1.3 0.0 2.9 0.0
International | Oncology        
Revenue from External Customer [Line Items]        
Total revenues $ 17.1 $ 21.3 $ 63.6 $ 54.0